MyFinsight
Home
Blog
About
Contact
Download
Download image
Short-term investments
$203,669K
Cash and cash
equivalents
$41,317K
Accounts receivable, net
$25,347K
Inventories
$8,369K
Prepaid expenses and
other current assets
$6,194K
Total current assets
$284,896K
Inventories, noncurrent
$23,053K
Intangible assets, net
$14,452K
Other assets
$2,786K
Property, plant and
equipment, net
$2,465K
Total assets
$327,652K
Total liabilities and
stockholders' equity
$327,652K
Total liabilities
$213,394K
Total stockholders'
equity
$114,258K
Accumulated deficit
-$294,603K
Term loans, net
(including related party...
$96,374K
Financing liability
$72,140K
Total current
liabilities
$39,145K
Other accrued
liabilities
$4,605K
Contract liability, net
of current portion
$1,130K
Additionalpaid-incapital
$408,726K
Accumulated other
comprehensive gain, net
$125K
Common stock, 0.0001
par value per share...
$10K
Accounts payable and
accrued liabilities...
$37,948K
Contract liability,
current
$609K
Other current
liabilities
$588K
Back
Back
Balance Sheet
source: myfinsight.com
ARS Pharmaceuticals, Inc. (SPRY)
ARS Pharmaceuticals, Inc. (SPRY)